789
+3.82%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Metacare Co
Its shares trade on KRX under the ticker 118000.KS. It has been listed since 30 December 2009. In the fiscal year to 31 December 2025, it reported revenue of ₩32.82bn and net income of ₩498.2m. At that date it held total assets of ₩197.96bn and shareholders' equity of ₩119.42bn.
MEDIPHARM Co., Ltd. engages in the manufacture, distribution, and sale of medical devices, and healthcare products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2009-12-30. The firm operates through five segments. The Pharmaceuticals Business segment is engaged in the distribution of pharmaceuticals including recapsules and tablets. The Medical Business segment is engaged in the distribution of medical devices and medical supplies. The Wireless Device segment is engaged in the manufacture of wearable wireless devices. The Video Content segment is engaged in the production of video products. The Investment segment is engaged in the management consulting and investment businesses.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 30 Dec 2009
- Employees
- 30
- Website
- chorokbaemhc.com ↗
Leadership
Pay as last reported
- Su Jin LeeChief Executive Officer, Director, since 2024
- Ms. Bu Gyeong HuhInternal Auditor
- Mr. Jin Su JungInternal Auditor
- Gwan Sik ChoiDirector
- Mr. Hong Su ChoiDirector
- Mr. Ji Seong HaDirector
- Su Gyeong KimDirector
- Seung Yeol LeeDirector, since 2009
- Byeong Yil SeoDirector
- Gyu Seong JungNon-Executive Independent Director
- Cheol Beom LeeNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- MEDIPHARM Co., Ltd. distributes pharmaceuticals including recapsules and tablets in the Pharmaceuticals Business segment.
- The Medical Business segment distributes medical devices and medical supplies across Korea.
- Wireless Device segment manufactures wearable wireless devices for healthcare applications.
Weaknesses
- The Video Content segment produces video products with limited market reach in Korea.
- The Investment segment manages consulting and investment businesses with low revenue contribution.
- The company has only 30 employees, limiting operational capacity in Korea.
Opportunities
- Expanding the Wireless Device segment into international markets for wearable technology.
- Increasing the Pharmaceuticals Business segment's distribution of recapsules and tablets.
- Growing the Medical Business segment in the Korean healthcare market.
Threats
- Competition from established medical device manufacturers in Korea.
- Regulatory changes affecting pharmaceutical distribution in Korea.
- Economic downturns impacting the Investment segment's consulting services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.